close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar6Point16
Implied share price

Sell Overvalued by 56.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
AFFX
Affymetrix, Inc.
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 22.94 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $6.16 $141.23 $169.44 $56.52 $80.16
Market Cap 1,128 130,102 107,921 100,042 98,744
Net Debt -14 47 7,450 -3,369 7,330
Enterprise Value (EV) 1,113 130,149 115,371 96,673 56,725
Revenue 359 21,662 32,639 13,418 34,861
EBITDA 48 10,657 23,287 5,661 11,136
Percent 13.5 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 26 8,530 22,189 5,069 7,186
Percent 7.4 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 546 71,449 51,716 21,787 102,321
Total Liabilities 207 43,366 33,182 6,116 44,272
Shareholders Equity 339 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.